Liquidia vs MannKind
LQDA and MNKD side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LQDA and MNKD compare
Liquidia is the larger company, worth 3.9 times as much as MannKind ($5.1B against $1.3B).
Liquidia grew revenue faster over the last twelve months (2234% versus 30.5% for MannKind).
Liquidia keeps more of each dollar of sales as profit, with a net margin of 30.7% compared with −11.1% at MannKind.
Liquidia scores higher on the StockData Score (8 against 6 for MannKind), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LQDA | MNKD |
|---|---|---|
| Size and price | ||
| Market cap | $5.1B | $1.3B |
| Share price | $56.73 | $4.07 |
| Change, 1 year | 102% | −19.6% |
| Change, 5 years | 1280% | −12.1% |
| Beta (5Y) | 1.00 | 1.98 |
| Employees | 216 | 241 |
| StockData Score | ||
| Total score | 8 (better) | 6 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 2 |
| Performance score | 3 (better) | 2 |
| Health score | 3 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 40.8× | – |
| P/S | 11.3× | 3.3× (better) |
| P/B | 26.0× | – |
| EV/EBITDA | 28.2× (better) | 39.8× |
| P/FCF | 33.7× | – |
| FCF yield | 3.0% (better) | −1.4% |
| Fair value | $32.46 | $1.79 |
| Margin of safety | −74.8% (better) | −127% |
| Growth | ||
| Revenue growth (TTM) | 2234% (better) | 30.5% |
| Revenue growth, 5Y average | 192% (better) | 39.9% |
| Net income growth (TTM) | – | −233% |
| EPS growth (TTM) | – | −218% |
| Profitability | ||
| Gross margin | – | 89.8% |
| Operating margin | 37.4% (better) | 2.3% |
| Net margin | 30.7% (better) | −11.1% |
| FCF margin | 33.4% (better) | −4.6% |
| Return on equity | 132% | – |
| Financial health | ||
| Interest coverage | 6.3× (better) | 0.3× |
| Current ratio | 2.31 (better) | 1.72 |
| Altman Z-score | 10.49 (better) | −4.45 |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 81.1% | 56.7% |
| Held by insiders | 19.5% | 2.5% |
| Insider net buying, 12 months | −$227M | −$2.9M (better) |
| Short interest, % of float | 24.3% | 8.4% |
Go deeper
- LQDA stock overview
- LQDA income statement
- LQDA valuation and score
- MNKD stock overview
- MNKD income statement
- MNKD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.